Siegall, W.
and Kelman, Z.
(2024),
Important consideration when expressing mAbs in Escherichia coli, Protein Expression and Purification, [online], https://doi.org/10.1016/j.pep.2024.106499, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=936482
(Accessed August 7, 2025)
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Important consideration when expressing mAbs in Escherichia coli
Published
Author(s)
William Siegall,
Abstract
Monoclonal antibodies (mAbs) are a driving force in the biopharmaceutical industry. The production of therapeutic mAbs is primarily done in mammalian cells, but recently there has been a push towards the use of alternative production hosts including Escherichia coli. When the genes encoding for the mAbs heavy and light chains are codon-optimized for E. coli expression it has been noted that a truncated form of the heavy chain can be formed along with the full-length product. Here, the observation of the factors that lead to a truncated product was expended to several therapeutic mAbs and optimization algorithms. Approaches to avoid this truncated form are discussed.Citation
Protein Expression and Purification
Pub Type
Journals
Download Paper
Keywords
E. coii, Protein expression, Codon optimization
Citation
Issues
If you have any questions about this publication or are having problems accessing it, please contact [email protected].
Created May 2, 2024, Updated August 1, 2025